EFPIA Newsletter 02 February 2023

Why Europe must future-proof its pharma legislation     Why Europe must future-proof its pharma regulation 31 January 2023   Despite a rich history in the discovery of new treatments and vaccines, Europe is going backwards when it comes to medical innovation. As a region, we have been falling behind global competitors in R&D and manufacturing, with lower investment, fewer clinical trials and longer approval times for new medicines for the last 25 years. We have one shot at making Europe an innovation hub. Failure is not an option. Read more →

News     31 January 2023 EFPIA update on the readiness for mandatory use of the Clinical Trials Regulation A majority of EFPIA members have already submitted at least one clinical trial application through the Clinical Trials... Read more →         30 January 2023 EBC & EFPIA hold RETHINKING Alzheimer’s event ahead of policy paper launch The European Brain Council (EBC), in collaboration with EFPIA, organised a digital event looking at the need to rethink... Read more →

Why Europe must future-proof its pharma legislation

Events     07 FEB 2023   Impacts of IVDR Implementation on Patient Access to Clinical Trials Online While the IVDR establishes a new regulatory framework for diagnostic tests in the EU to ensure test accuracy and patient... Learn more →       08 FEB 2023   Time to act: Building a pharmaceutical framework fit for rare diseases European Parliament, 60 Rue Wiertz, 1047, Bruxelles Join MEP Stelios Kympouropoulos in discussing the once-in-a-generation revision of the European pharmaceutical framework... Learn more →

	09 FEB 2023			ACCELERATE 2023 Annual Conference Brussels & online All sessions, including Breakout Sessions, will be available for both in-person and online participants. Learn more →

	15 FEB 2023			AMR: New incentives – a call for action Virtual The webinar will discuss the need for new economic pull incentives that can lead to the development of new and novel... Learn more →

What we are reading Why EU capitals fear Brussels has got Ukraine’s hopes too high 01 February 2023  (Financial Times) Read more → Requests for EMA PRIME designation fall but improvements are on the way 26 January 2023  (Pink Sheet) Read more →

About the EFPIA newsletter The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55 Communications@efpia.eu ▶ in

EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe